Zhongwei Zhang
CIK: 0002122235
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AARD
Aardvark Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About Zhang Zhongwei
Zhang Zhongwei (SEC CIK 0002122235) files insider reports with the SEC as Director of Aardvark Therapeutics, Inc. (AARD).
Signal8 holds 2 ownership filings by Zhang Zhongwei (1 Form 3, 1 Form 4), filed on Oct 8, 2026. Those filings report 1 transaction, the latest on Oct 7, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Zhang Zhongwei's filings is in SAN DIEGO, CA.
Recent filings by Zhang Zhongwei
- Oct 7, 2026: Grant or award of AARD derivative securities (Form 4, code A).
Other insiders filing for Aardvark Therapeutics, Inc. (AARD)
- Sun Nelson
- Chi Jeffrey, Director
- Graf Susan E, Director
- Baynes Roy D., Director
- Tong Victor Edward Jr, Director
- Jaiman Manasi, Chief Medical Officer